Jan 21, 2026
In this episode, we explore how GLP-1 agonists—the weight loss medications making headlines everywhere—could revolutionize management of antipsychotic-induced weight gain. Can these drugs help patients lose weight while maintaining psychiatric stability? We examine the latest evidence and discuss practical implementation strategies for your practice.
Faculty: Oliver Freudenreich, M.D.
Host: Richard Seeber, M.D.